AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05810519 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active break with the proposed lumbar and hip extension exercises
Description: Participants assigned to the experimental group will receive recommendation to take an active break with the proposed lumbar and hip extension exercises for every 30 minutes of sitting. In the experimental intervention, the exercise program include exercises and will be based on patient education. The participants will also explain the importance of regular training and receive a booklet with photographed and described exercises.
Study NCT05810519 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-care recommendations
Description: Participants assigned to the control group will receive an educational self-care book containing information on low back pain, anatomy of the spine and its relation to the muscular chain, care during daily life activities and the importance of regular physical exercises. The control group will perform their regular baseline activities.
Study NCT00057161 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Coordinated Representative Payeeship with Case Management
Study NCT06400667 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Upper limb Kinematic Assessment with Optoelectronic system
Description: All measurements will be obtained using an optoelectronic multicamera system for human motion analysis (with eight high-resolution cameras with infrared light and a sampling frequency of 60 Hz. The experimental protocol require the positioning of markers (plastic spheres covered by reflecting film, 10 mm in diameter). Markers will be placed by clinical operators (physiotherapists with training in optoelectronic system for human motion analysis) after training and experience in recognition of the position of body landmarks. During the data acquisition protocol, the subject perform five trial for each upper limb of a determinate functional task for each session. Every subject repeat this operations 2 times with 2 different operators.
Study NCT04790786 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Lilly Bamlanivimab
Description: Administration of Lilly Bamlanivimab to COVID positive patients
Study NCT05425485 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Multi-component intervention
Description: Web-based strategy with processes, materials, and patient and doctor education formats.
Study NCT06405230 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab will be administered.
Study NCT06405230 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Dostarlimab
Description: Dostarlimab will be administered.
Study NCT06405230 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed+ (carboplatin or cisplatin)
Description: PBCD consisting of pemetrexed+ (carboplatin or cisplatin) will be administered.
Study NCT04790786 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Regeneron Casirivimab + Imdevimab
Description: Administration of Regeneron Casirivimab + Imdevimab to COVID positive patients
Study NCT04790786 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Lilly Bamlanivimab + Etesevimab
Description: Administration of Lilly Bamlanivimab + Etesevimab to COVID positive patients
Study NCT04790786 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Sotrovimab
Description: Administration of Sotrovimab to COVID positive patients
Study NCT04790786 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bebtelovimab
Description: Administration of Bebtelovimab to COVID positive patients
Study NCT05656157 — intervention group
Intervention type: DEVICE
Intervention: Medical device
Description: Clinical decision support system
Study NCT06206863 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise Intervention
Description: Participate in virtual exercise classes
Study NCT06467448 — intervention group
Intervention type: DEVICE
Intervention: EMG Assessement of Recovery of Neuromuscular Function
Description: EMG Train of Four Assessment of Recovery of Neuromuscular Function
Study NCT06206863 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT05544084 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Patient Navigator Approach
Description: Patient navigators in collaboration with community health workers will work with women eligible for cervical cancer screening to overcome intrapersonal and community level barriers to screening in order to engage early with the health system for cervical cancer screening and follow-up of positive screens. Their support can help patients get the cancer screenings and follow-up care they need, while addressing prevalent gender inequities and community-level stigma associated with cancer within the Senegal context.
Study NCT05326217 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Description: The aerobic exercise :In this study, the exercise intensity is set based on the subject's maximum heart rate, and the target heart rate is adjusted according to the literature to reach 60-90% of the maximum heart rate. A gradual increase of intermittent exercise will be designed for current exercise prescription. In terms of exercise frequency and time, there will be two times interventions per week for at least 60 minutes per time (including warm-up and cool down exercises).
Study NCT05326217 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistant exercise
Description: The resistant exercise : muscular endurance (15-20RM) and muscular hypertrophy (8-12RM) are applied to main exercise intensity. The intensity is gradually adjusted according to the state of each subject, and the intervention is performed twice a week (50 minutes per time).The target muscles of resistance training include quadriceps femoris, biceps femoris, calf muscles, core muscles (including pelvic floor muscles), back muscles, pectoralis major, biceps/triceps and other muscle groups.
Study NCT04764994 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Armeo®Spring ((Task-oriented upper extremity rehabilitation system)
Description: Armeo®Spring is a functional upper extremity rehabilitation device to provide specific therapy with augmented feedback. The Armeo Spring instrument facilitates intensive task-oriented upper extremity therapy after stroke, traumatic brain injury or other neurological diseases and injuries. It combines an adjustable arm support, with augmented feedback and a large 3D workspace that allows functional therapy exercises in a virtual reality environment.
Study NCT04764994 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Physical Therapy Program
Description: This intervention t will include: muscle facilitation exercises, proprioceptive neuromuscular facilitation exercises, strengthening activities, stretching exercises and postural reactions exercises.
Study NCT04764994 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Physical Therapy Program
Description: This intervention t will include: muscle facilitation exercises, proprioceptive neuromuscular facilitation exercises, strengthening activities, stretching exercises and postural reactions exercises.
Study NCT06465446 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: IV infusion
Study NCT06465446 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IMM01
Description: 2.0mg/kg, IV infusion
Study NCT05603507 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: inspiratory muscle training
Description: training done with a pressure threshold-loading device
Study NCT05603507 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pulmonary rehabilitation
Description: Circuit training of aerobic and resistive exercise
Study NCT05603507 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: pulmonary rehabilitation
Description: Circuit training of aerobic and resistive exercise
Study NCT04953117 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DCB of Lepu Medical(dimeter≥2.00 mm)
Description: subjects receiving DCB of Lepu Medical(dimeter≥2.00 mm)
Study NCT04953117 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Restore DEB
Description: subjects receiving Restore DEB
Study NCT04953117 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: DCB of Lepu Medical(dimeter<2.00 mm)
Description: subjects receiving DCB of Lepu Medical(dimeter\<2.00 mm)
Study NCT04946630 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PreciseInhale
Description: Three different settings of the medical device PreciseInhale will be used in the study; PreciseInhale Whole Lung Exposure, PreciseInhale Bronchial Bolus/Breath hold Exposure and PreciseInhale Alveolar Bolus/Breath hold Exposure.
Study NCT04946630 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Seretide Evohaler forte
Description: Single dose of Seretide Evohaler forte (fluticasone propionate/salmeterol 250 µg/25 µg) administered according to SmPc or via the PreciseInhale system.
Study NCT06465446 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bendamustine
Description: IV infusion
Study NCT06465446 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemcitabine
Description: IV infusion
Study NCT06013072 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dietary Supplement: Experimental
Description: Combination of pre-probiotic
Study NCT06013072 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Dietary Supplement: Placebo
Description: Inert compound
Study NCT05574452 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ACL reconstruction using the SONAR Femoral Aimer PSI
Description: ACL reconstruction using the SONAR Femoral Aimer PSI
Study NCT05543330 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: M701 pleural infusion
Description: M701 pleural infusion on Days 1,4,7 and 10.
Study NCT05543330 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Pleural drainage
Description: Pleural effusion drainage via Ultra-sound guidance on Day 1.
Study NCT05543330 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pleural drainage
Description: Pleural effusion drainage via Ultra-sound guidance on Day 1.
Study NCT05543330 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Cisplatin pleural infusion
Description: Cisplatin pleural infusion (30-50mg/m2) on Day 1.
Study NCT04877652 — intervention group
Intervention type: OTHER
Intervention: Standard of care
Description: Standard medical treatment of ADHF patients deemed to have insufficient diuretic response.
Study NCT04773678 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CBP-201
Description: CBP-201 subcutaneous (SC) injection.
Study NCT05045469 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dian dao san
Description: dian dao san and placebo will be used in the rosacea lesions twice a day for 6 weeks
Study NCT05045469 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: dian dao san
Description: dian dao san and placebo will be used in the rosacea lesions twice a day for 6 weeks
Study NCT04773678 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo subcutaneous (SC) injection.
Study NCT05264844 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Masking tape
Description: IV catheters will be fixed with masking tape
Study NCT06335628 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Geistlich Fibro-Gide®
Description: Geistlich Fibro-Gide® is intended to be used as an implantable device for regeneration and augmentation of soft tissue in oral and maxillofacial surgery.
Study NCT06277141 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard message
Description: Participants will receive standard messaging based on the Cancer Association of South Africa (CANSA) recommendation on breast cancer screening and a reminder to screen for breast cancer.
Study NCT06277141 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Radiology booking site link.
Description: Participants will receive a reminder to screen for breast cancer with a direct online link to a radiology practice booking site.
Study NCT06277141 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Radiology practice telephone numbers
Description: Participants will receive a reminder to screen for breast cancer together with a list and telephone numbers of radiology practices
Study NCT06277141 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Radiology site link and telephone numbers
Description: Participants will receive a reminder to screen for breast cancer with a direct online link to a radiology practice booking site and a list and telephone numbers of radiology practices
Study NCT06348056 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 30 mg Zn Amino Acid daily for 13 days
Description: A 30 mg zinc amino acid supplement is taken p.o. in the fasted state for 13 days.
Study NCT06348056 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 30 mg Zn Gluconate daily for 13 days
Description: A 30 mg zinc gluconate supplement is taken p.o. in the fasted state for 13 days.
Study NCT04586153 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Meplazumab for Injection
Description: humanized antibody target CD147
Study NCT04586153 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sterile normal saline (0.9%)
Description: Sterile normal saline (0.9%)
Study NCT04690036 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: toripalimab injection
Description: when EBV-DNA is positive after allo-HCT, and EBV infected T/NK cell, one dose of toripalimab 3mg/kg would be used, the same dose would be repeated 4 weeks later.
Study NCT05485220 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Description: Aerobic exercise group: Peak workload will be determined by performing an exercise test on the patients. Training will be given at 60-70% of the peak workload for 45 minutes with an arm ergometer 3 days a week for 8 weeks.
Study NCT05485220 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High-intensity interval training
Description: High-intensity interval training Group: Peak workload will be determined by performing an exercise test on the patients and arm ergometer HIIT will be done with a total of 45 minutes, 90-95% of the peak workload for 30 seconds, 60 seconds in between, active recovery at 40-50% workload, 3 days a week for 8 weeks.
Study NCT04717141 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Selective nerve block
Description: D0 :~* Information, collection of consent, inclusion,~* Clinical and instrumental evaluation,~* Realization of the selective nerve block,~* Post-selective nerve block clinical and instrumental re-evaluation,~* Performance of the botulinum toxin injection if indication selected.~D28 (+/-5 days) :~- Clinical and instrumental post-botulinum toxin injection evaluation.
Study NCT05630170 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AI-ECG
Description: A novel AI-ECG model developed at the Cardiovascular Data Science (CarDS) lab will be used as Software as Medical Device (SaMD) on ECG images for detection of LVSD.
Study NCT04617392 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopic sleeve gastrectomy
Description: Sleeve gastrectomy involves removing a part of the stomach, limiting the amount of food the patient can eat.
Study NCT04617392 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic sleeve gastrectomy
Description: Sleeve gastrectomy involves removing a part of the stomach, limiting the amount of food the patient can eat.
Study NCT04617392 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Strength endurance training
Description: Patients included in the active cohort arm with physical activity will undergo three months of strength endurance training under the supervision of a professional physiotherapist
Study NCT05208372 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: CTC test
Description: Circulating tumor cells test of ascites and blood for patients with gastric cancer.
Study NCT05208372 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: ctDNA test
Description: Circulating tumor DNA test of ascites and blood for patients with gastric cancer.
Study NCT06478992 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: A:hysteroscopic suture fixation of Mirena
Description: A(the thickness of the thickest uterine myometrium ≥30mm ):The Mirena is fixed to the uterine wall under hysteroscopy, and the endometrial tissue was routinely aspirated and scraped during the operation and sent for pathological examination.
Study NCT06478992 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: A: simple Mirena placement under hysteroscopy
Description: A(the thickness of the thickest uterine myometrium ≥30mm):Mirena is routinely placed in the uterine cavity under hysteroscopy, and endometrial tissue was routinely aspirated and scraped during the operation and sent for pathological examination.
Study NCT06478992 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: B: hysteroscopic suture fixation of Mirena
Description: B(the thickness of the thickest uterine myometrium\<30mm):The Mirena is fixed to the uterine wall under hysteroscopy, and the endometrial tissue was routinely aspirated and scraped during the operation and sent for pathological examination.
Study NCT06478992 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: B：simple Mirena placement under hysteroscopy
Description: B(the thickness of the thickest uterine myometrium\<30mm):Mirena is routinely placed in the uterine cavity under hysteroscopy, and endometrial tissue was routinely aspirated and scraped during the operation and sent for pathological examination.
Study NCT05425199 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Habituation exercises + vestibular treatment
Description: Exercises will include Intensity: 10 repetitions of each set Frequency= 3 sessions per week for 6 weeks.~Time= 30 minutes
Study NCT05425199 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: proprioceptive training + vestibular therapy
Description: Exercise protocol will include Time= total session of 30 minutes . Each exercise will be hold for 30 seconds . Frequency= 3 session per week for 6 weeks Intensity= 10 repetitions and 3 sets
Study NCT05425199 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional vestibular treatment
Description: Epley's Manuever. Frequency= It will be performed once in a week . Time= 10-15 minutes per session
Study NCT06394271 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EVAR
Description: Catheter based insertion of aortic endograft via iliac or femoral arteries
Study NCT05123612 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fiber
Description: Additional 20 grams of fiber/day.
Study NCT05123612 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fermented Foods
Description: 6 servings of fermented foods/day
Study NCT04516408 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant zoster vaccine
Description: Recombinant zoster vaccine (RZV) is indicated for prevention of herpes zoster in adults aged ≥ 50 years old. RZV contains a varicella zoster virus glycoprotein E antigen and the AS01B adjuvant system.
Study NCT04516408 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Sterilized water
Study NCT05532579 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Invasive Physiotherapy Group
Description: The study participants corresponding to the intervention group will receive the treatment proposed by their medical doctor. In addition, and as the main part of the intervention, they will receive an invasive physiotherapy protocol consisting of 3 sessions of ultrasound-guided percutaneous neuromodulation, with a time margin of one week between the first and second session and two weeks between the second and third session. The session will last approximately 15 minutes. Each treatment session will consist of the application of a symmetric biphasic current of 3Hz frequency, 250µsec pulse width, 10 impacts of 10 seconds duration with 10 seconds of rest between them. This application will be performed with acupuncture needles placed in an echoguided manner in the proximity of the dorsal root of the last 3 lumbar levels and in the proximity of the sciatic nerve at its exit from the piriformis muscle.
Study NCT05532579 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Sham Group
Description: Study participants corresponding to the sham group will receive the treatment proposed by their medical doctor. In addition, they will receive the application of the simulated transcutaneous electrical stimulation technique, placing the patches on the same points where the needles are located, remaining in prone position for the necessary time after the technique is performed until 15 minutes have elapsed. This technique has been studied as a placebo technique for neuromodulation interventions.
Study NCT05804721 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apipe (Aripiprazole10 mg)
Description: Test drug
Study NCT05804721 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Abilify (Aripiprazole10 mg)
Description: Reference drug